Metlife (NYSE:MET)‘s stock had its “buy” rating reissued by equities research analysts at Keefe, Bruyette & Woods in a report released on Friday. They currently have a $56.00 price target on the financial services provider’s stock. Keefe, Bruyette & Woods’ price objective suggests a potential upside of 17.97% from the stock’s previous close.
MET has been the topic of several other research reports. ValuEngine lowered shares of Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research lowered shares of Metlife from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. Royal Bank of Canada reissued an “outperform” rating and issued a $60.00 price target (up previously from $56.00) on shares of Metlife in a research report on Friday, November 3rd. Deutsche Bank started coverage on shares of Metlife in a research report on Tuesday, January 2nd. They issued a “hold” rating and a $55.00 price target on the stock. Finally, Argus boosted their price target on shares of Metlife from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, November 6th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $57.58.
Shares of Metlife (NYSE MET) traded up $0.84 during mid-day trading on Friday, reaching $47.47. 4,341,881 shares of the company’s stock traded hands, compared to its average volume of 8,910,000. The company has a market capitalization of $49,950.00, a price-to-earnings ratio of 11.69, a price-to-earnings-growth ratio of 0.95 and a beta of 1.31. The company has a current ratio of 0.15, a quick ratio of 0.16 and a debt-to-equity ratio of 0.29. Metlife has a twelve month low of $43.38 and a twelve month high of $55.91.
A number of institutional investors have recently bought and sold shares of MET. TIAA FSB increased its holdings in Metlife by 50.6% during the 3rd quarter. TIAA FSB now owns 32,564 shares of the financial services provider’s stock worth $1,692,000 after acquiring an additional 10,941 shares during the period. Aperio Group LLC increased its holdings in Metlife by 0.6% during the 3rd quarter. Aperio Group LLC now owns 483,392 shares of the financial services provider’s stock worth $25,112,000 after acquiring an additional 2,948 shares during the period. Korea Investment CORP increased its holdings in Metlife by 30.0% during the 3rd quarter. Korea Investment CORP now owns 858,812 shares of the financial services provider’s stock worth $44,615,000 after acquiring an additional 198,100 shares during the period. Supplemental Annuity Collective Trust of NJ increased its holdings in Metlife by 7.2% during the 3rd quarter. Supplemental Annuity Collective Trust of NJ now owns 20,000 shares of the financial services provider’s stock worth $1,039,000 after acquiring an additional 1,344 shares during the period. Finally, New Jersey Better Educational Savings Trust bought a new stake in Metlife during the 3rd quarter worth approximately $520,000. 76.25% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This piece of content was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2018/02/24/metlife-met-stock-rating-reaffirmed-by-keefe-bruyette-woods.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.